# FDA recall D-0223-2024

> **Dr. Reddy's Laboratories, Inc.** · Class II · drug recall initiated 2024-01-02.

## Product

Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15

## Reason for recall

Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.

## Distribution

USA Nationwide

## Key facts

- **Recall number:** D-0223-2024
- **Recalling firm:** Dr. Reddy's Laboratories, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Completed
- **Initiation date:** 2024-01-02
- **Report date:** 2024-01-17

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Princeton, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0223-2024

## Citation

> AI Analytics. FDA recall D-0223-2024. Retrieved 2026-07-26 from https://api.ai-analytics.org/recall/D-0223-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*